Hudson Executive Capital Lp buys $50,190,989 stake in HeartWare International Inc (HTWR)

HeartWare International Inc (HTWR) : Hudson Executive Capital Lp scooped up 346,000 additional shares in HeartWare International Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 866,258 shares of HeartWare International Inc which is valued at $50,190,989.HeartWare International Inc makes up approximately 17.17% of Hudson Executive Capital Lp’s portfolio.

Other Hedge Funds, Including , Two Sigma Advisers Lp reduced its stake in HTWR by selling 12,500 shares or 9.32% in the most recent quarter. The Hedge Fund company now holds 121,651 shares of HTWR which is valued at $7,048,459. HeartWare International Inc makes up approx 0.03% of Two Sigma Advisers Lp’s portfolio.United Services Automobile Association reduced its stake in HTWR by selling 430 shares or 2.72% in the most recent quarter. The Hedge Fund company now holds 15,370 shares of HTWR which is valued at $890,538. Royal London Asset Management Ltd sold out all of its stake in HTWR during the most recent quarter. The investment firm sold 24,104 shares of HTWR which is valued $1,396,586. Meeder Asset Management Inc added HTWR to its portfolio by purchasing 5,736 company shares during the most recent quarter which is valued at $331,311. HeartWare International Inc makes up approx 0.03% of Meeder Asset Management Inc’s portfolio.Simplex Trading boosted its stake in HTWR in the latest quarter, The investment management firm added 13,598 additional shares and now holds a total of 15,483 shares of HeartWare International Inc which is valued at $894,143. HeartWare International Inc makes up approx 0.11% of Simplex Trading’s portfolio.

On the company’s financial health, HeartWare International Inc reported $-0.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.19 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $-0.81. The company had revenue of $68.72 million for the quarter, compared to analysts expectations of $57.36 million. The company’s revenue was down -6.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.47 EPS.

Many Wall Street Analysts have commented on HeartWare International Inc. HeartWare International Inc was Downgraded by Raymond James to ” Mkt Perform” on Jul 13, 2016. HeartWare International Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 11, 2016. HeartWare International Inc was Downgraded by Wells Fargo to ” Market Perform” on Jun 29, 2016.

Heartware International Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System) which includes a ventricular assist device (VAD) or blood pump patient accessories and surgical tools provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart avoiding abdominal surgery directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller which circulates a cushion of blood.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

HeartWare International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on HeartWare International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.